產(chǎn)品詳情
所在位置: 首頁> 產(chǎn)品目錄> 試劑>

  • 產(chǎn)品名稱：Gefitinib(ZD1839)

  • 產(chǎn)品型號：
  • 產(chǎn)品廠商：TargetMol
  • 產(chǎn)品文檔：
你添加了1件商品 查看購物車
簡單介紹：
Gefitinib(ZD1839)
詳情介紹：
Purpose Gefitinib (originally coded ZD1839) is a drug used in the treatment of certain types of cancer. Acting in a similar manner to erlotinib (marketed as Tarceva), gefitinib selectively targets the mutant proteins in malignant cells. It is marketed by AstraZeneca under the trade name Iressa.
Characteristics Tradename: IRESSA
Source of Compound: synthetic, ZD-1839
Target: EGFR antagonist
Receptor: EGFR
Status: USAN, INN, BAN
Purification All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
Purity 99?%
Formula C22H24ClFN4O3
Solubility Sparingly soluble in water
Molecular Weight 446.91 g/mol
CAS-No 184475-35-2
Application Notes Optimal working dilution should be determined by the investigator.
Restrictions For Research Use only
Format Solid
Storage -20 °C
Storage Comment For the majority of compounds, they could be dissolved in DMSO or other organic solvent.
Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience.
Several freeze/thaw cycles should not damage the activity of our small molecule products.
However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours.
Expiry Date 24 months